Pattern of treatment failures in patients with central nervous system non-germinomatous germ cell tumors (CNS-NGGCT): A pooled analysis of clinical trials.
Adriana FonsecaCecile Faure ConterMatthew Jonathan MurrayJason R FangusaroShivani BaileyStewart GoldmanSoumen KhatuaDidier FrappazGabriele CalaminusGirish DhallJames C NicholsonEric BouffetUte BartelsPublished in: Neuro-oncology (2022)
Herein, we present the largest pooled dataset of prospectively treated patients with relapsed CNS-NGGCT. Our study identified younger age and negative tumor markers to be characteristic of GTS. Additionally, we elucidated that metastatic relapses occur earlier than local relapses are associated with elevated tumor markers and are not associated with the field of radiation therapy. These findings are of utmost importance for the planning of future clinical trials and the implementation of surveillance strategies in these patients.
Keyphrases
- clinical trial
- radiation therapy
- end stage renal disease
- germ cell
- newly diagnosed
- ejection fraction
- blood brain barrier
- chronic kidney disease
- healthcare
- acute lymphoblastic leukemia
- small cell lung cancer
- acute myeloid leukemia
- phase iii
- public health
- primary care
- prognostic factors
- diffuse large b cell lymphoma
- peritoneal dialysis
- randomized controlled trial
- quality improvement
- open label
- study protocol